U.S. Mortgage Finance Stock News

Workday stock has rebounded sharply in the past month, while valuation checks are mixed. An intrinsic value estimate from a Discounted Cash Flow (DCF) model points to upside, whereas market multiples suggest the shares are not cheap. The stock is up 47.1% over the past month, which puts recent price action well ahead of its returns over longer periods. Ongoing buyout talks with private equity firm Silver Lake and Workday's push into enterprise AI research can support optimism about future...

Graham Corporation recently reported a very strong Q2, with revenue rising 28.6% year over year and both earnings and EBITDA surpassing analyst expectations. This outperformance highlights how Graham’s current operations are converting existing backlog into stronger results, offering fresh context for its longer-term story. With Q2 revenue and earnings beating analyst expectations, we’ll now examine how this performance may influence Graham’s existing investment narrative. Find 49 companies...

Best Buy (BBY) is back in focus after fresh analyst forecasts highlighted expectations for year-over-year changes in earnings and revenue, with attention on margin dynamics and how upcoming management guidance could influence investor sentiment. See our latest analysis for Best Buy. The recent analyst forecasts arrive after a strong run in Best Buy's share price, with a 38.37% 90 day share price return and a 26.45% year to date move, while the 5 year total shareholder return is down 7.02%...

Comfort Systems USA (FIX) is back in focus after reporting Q2 2026 results that included a 50% year over year revenue increase, record backlog levels, and strong free cash flow supported by expanding modular operations. See our latest analysis for Comfort Systems USA. Despite the strong Q2 update, Comfort Systems USA’s recent share price has been under pressure, with the stock down 14% over the past week and 15% over the past three months. This comes even as the year-to-date share price...

JetBlue announced that its second BlueHouse airport lounge opened at Boston Logan’s Terminal C on August 27, 2026, expanding complimentary access to all eligible Mint and Mint Flex customers and reinforcing Boston as its second-largest focus city. An interesting angle is JetBlue’s introduction of the new Mint Base fare, which widens access to its premium onboard product while deliberately withholding lounge entry, effectively tiering the premium experience and monetizing BlueHouse access...

Ovintiv (OVV) is back in focus after updating investors on higher full year oil and condensate production guidance while keeping capital spending unchanged, signaling a shift in capital efficiency and cash generation priorities. See our latest analysis for Ovintiv. Ovintiv’s recent update sits against a strong run in the stock, with a 62.81% year to date share price return and a 178.80% five year total shareholder return pointing to sustained momentum rather than a short spike in...

Tariffs on Canadian autos, parts and steel set for 2027 have jolted the story of North American manufacturing, and suddenly onshoring is more than just a political slogan. Supply chains that once treated the border as a formality now face fresh friction, which could shift where factories, warehouses and jobs sit. This article looks at three U.S. manufacturers exposed to that news and how this shift could shape their risk and potential. The stocks highlighted below are just a starting sample,...

Why the new Missile Defense Agency contract matters for Parsons stock Parsons (PSN) just secured a new US$514 million contract option from the Missile Defense Agency, extending its role in engineering and technical support for the integrated Missile Defense System. For investors, this multi year award confirms ongoing demand for Parsons' defense focused engineering capabilities and adds contracted revenue visibility tied to missile defense work at a time when the stock has recently...

Teladoc Health stock has fallen sharply over the past few years, yet the current checks suggest the shares may now be trading below what the intrinsic value estimates imply. With the Discounted Cash Flow (DCF) work pointing to a large gap between price and estimated value, investors are weighing that against a long run of weak share price performance. Teladoc Health has declined 95.7% over the past 5 years, which means any potential undervaluation today needs to be weighed against a very...

Riot Platforms (NasdaqCM: RIOT) is poised for a substantial release of pledged Bitcoin collateral that could expand its unrestricted Bitcoin pool by over 20% following the recent rally in Bitcoin prices. The potential shift would increase the portion of Bitcoin holdings Riot Platforms can access without repaying existing loans. A larger unrestricted Bitcoin balance could provide additional flexibility to support Riot Platforms' data center buildout and growing AI related operations. This...

Why Brookfield Wealth Solutions stock is in focus now Brookfield Wealth Solutions (BNT) is back on investor radar after its August 13 earnings release showed higher second quarter and first half revenue, alongside a sharp hit to profitability and a swing to a six month net loss. The company also affirmed a quarterly return of capital of $0.07 per class A and class B share, payable on September 29 to shareholders of record on September 14. This keeps capital returns in play despite the weaker...

Legal and Governance Updates Around Snap Stock A recent legal twist, with a teen plaintiff dropping claims against Snap (SNAP) alongside Meta Platforms and Google, has refocused attention on litigation risk and regulatory scrutiny for the social media company. The dropped claims relate to allegations that major platforms deliberately addict young users and contribute to mental health issues. TikTok had previously settled related claims, while Meta is still defending similar lawsuits brought...

Warner Bros. Discovery (WBD) is back in focus after California's attorney general pushed for deeper structural concessions tied to the proposed Paramount Skydance merger, including potential divestitures of certain cable assets. See our latest analysis for Warner Bros. Discovery. The latest headlines arrive after a very strong period for Warner Bros. Discovery, with a 1-year total shareholder return of 138.37% and a 3-year total shareholder return of 124.39%. The recent 11.37% 1-month share...

In August 2026, S&P Global announced an expanded collaboration with Microsoft to pipe its AI-ready data, insights, and analytics directly into Microsoft 365 Copilot, including Excel connectors and agentic plugins powered by its Kensho AI Data Portal. This move effectively embeds S&P Global’s proprietary intelligence into everyday productivity workflows, potentially making its data more indispensable to customers’ research, financial analysis, and benchmarking processes. We’ll now explore how...

Teva Pharmaceutical Industries (NYSE:TEVA) is back in focus after the U.S. Food and Drug Administration accepted its New Drug Application for ecopipam, an investigational pediatric Tourette syndrome treatment with Orphan Drug status. See our latest analysis for Teva Pharmaceutical Industries. The ecopipam news lands after a strong run for Teva Pharmaceutical Industries, with a 30 day share price return of 19.86% and a 1 year total shareholder return of 103.81% that signals building momentum...

NRG Energy (NRG) stock is back in focus after NRG Business Marketing LLC filed a limited protest with the Federal Energy Regulatory Commission regarding PJM Interconnection’s proposed Reliability Backstop Procurement framework. See our latest analysis for NRG Energy. Against this regulatory backdrop, NRG Energy’s share price has come under pressure, with the 30 day share price return down 20.74% and the year to date share price return down 32.73%, even though the 3 year total shareholder...

The latest focus on new liver cirrhosis therapies has put Mirum Pharmaceuticals (MIRM) in the spotlight, as its Volixibat candidate features among emerging drugs being tracked across this developing treatment market. See our latest analysis for Mirum Pharmaceuticals. Despite the spotlight on Volixibat, Mirum Pharmaceuticals' share price has softened recently, with a 30 day share price return of down 14.43% and a 7 day share price return of down 3.12%. However, the 1 year total shareholder...

NVIDIA (NVDA) stock is back in focus after Lancium announced a collaboration that will use NVIDIA’s full-stack AI factory platform across campuses representing 4 gigawatts of leased capacity and a 15 gigawatt development pipeline. See our latest analysis for NVIDIA. Despite the collaboration news and a busy August that includes AI alliances, infrastructure investments and an earnings report due on 26 August 2026, NVIDIA’s share price return has eased in the short term, with a 7 day share...

Agnico Eagle Mines stock has delivered a very large 3 year gain, yet the current intrinsic value estimate using a Discounted Cash Flow (DCF) approach points to the shares trading at a premium, while the earnings based multiples look closer to fair value. That split, together with a low overall value score, gives investors a lot to weigh up after such a strong run. Over the past 3 years, Agnico Eagle Mines has returned about 3.8x. This puts recent enthusiasm front and centre for anyone...

Copa Holdings stock reaction and recent performance Copa Holdings (NYSE:CPA) is drawing investor attention after a recent move in its share price, with the stock closing at US$131.50 as of 24 August 2026. The stock is up about 1.2% over the past day, while showing declines over the past week, month and past 3 months, which may prompt investors to reassess how Copa Holdings fits into their portfolio. See our latest analysis for Copa Holdings. That short term softness, with the 7 day and 90 day...

Technical setup takes shape after early August sell off TG Therapeutics (TGTX) is back in focus after the stock formed a cup style base following a sell off in early August, with shares now testing a key moving average. This type of technical setup often interests traders who follow price patterns. It can highlight areas where buying and selling pressure may be starting to rebalance after a sharp move. See our latest analysis for TG Therapeutics. For context, TG Therapeutics has seen strong...

Mueller Water Products has delivered an 86.9% gain over the past three years. Current valuation work suggests the stock may still trade below its intrinsic value based on a Discounted Cash Flow (DCF) estimate, even as its earnings multiples look roughly in line with the market. The share price return of 86.9% over three years signals that investors have already priced in a meaningful improvement in Mueller Water Products’ prospects. Future cash flow growth from its core water infrastructure...

Earlier this year, Delta Air Lines disclosed that it is testing artificial intelligence on about 3% of its fares to optimize ticket pricing, while CEO Ed Bastian suggested AI could eventually lift profitability significantly by improving decision-making and reducing costs, all under a stated commitment to legal and non-discriminatory pricing practices. Alongside these technology trials, research firm Zacks has highlighted Delta’s strong earnings outlook and value metrics, reinforcing...

Micron Technology has turned a very strong three year share price run into a live valuation debate, with the stock up about 13x over that period while the broader checks point to a more mixed picture instead of a clear bargain or clear excess. Micron has delivered roughly 1,310.6% over three years, which puts recent pullbacks into context and raises the bar for what needs to go right from here for new buyers. Heavy investment in AI focused memory projects such as the new research labs and...